The Global Blood Plasma market is slated to account for a CAGR of 6.62% by the end of the forecast period of 2018-2026
The Global Blood Plasma market is driven by factors like growing patient pool for haemophilia, the
high prevalence of alpha-1
antitrypsin deficiency and the advent of new therapeutic indications. By the
end of the forecast period of 2018-2026, the market is slated to account for a
CAGR of 6.62%.
MARKET
INSIGHTS
The global blood plasma market
is segmented according to the blood type, applications and end-users. The blood
type segment includes Intravenous
immunoglobulin, Immunoglobulin, Subcutaneous immunoglobulin, and other
immunoglobulin type along with Hyperimmune, Albumin, Coagulation factor concentrates and other plasma fractionation products. Blood plasma finds its
application in oncology, immunology, pulmonology, transplantation,
rheumatology, neurology, haematology and
other applications. The end-users for this market are academic institutions,
research laboratories and hospitals and clinics.
REGIONAL
INSIGHTS
Regional segmentation of the
global blood plasma market is done into North America, Europe, Asia-Pacific and
rest of the world. The North American market is expected
to continue having the upper hand over
other regional markets throughout the projected years of 2018-2026. Increase in
the prevalence of disorders like leukaemia, haemophilia, and other blood
disorders are expected to increase the market demand further in this region.
The highest CAGR by the end of the forecast period is expected from the
Asia-Pacific market. Several non-profit organizations such as the Asia-Pacific
Blood Network (APBN) are actively involved in ensuring that there is an
increased plasma supply in the APAC region.
COMPETITIVE
INSIGHTS
Leading companies such as Adma
Biologics Inc, Arthrex, Baxter International Inc, Biotest Ag, Cerus Corp, China
Biologic Products Inc, Csl Ltd, General Electric Co, Grifols International S.A,
Octopharma Ag, and Shire Plc are actively engaged in this market.
Geographically, the Global Blood Plasma market has been segmented on the basis of four major regions, which include:
North America Blood Plasma Market: The United States & Canada
Asia-Pacific Blood Plasma Market: China, India, Japan, Australia & Rest of APAC
Europe Blood Plasma Market: The United Kingdom, France, Germany & Rest of Europe

Comments
Post a Comment